Abstract
MYASTHENIA GRAVIS (MG) is a neuromuscular junction disease of man characterised by muscular weakness and fatigability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abramsky, O., Aharonov, A., Webb, C., and Fuchs, S., Clin. exp. Immun., 19, 11–16 (1975).
Abramsky, O., Aharonov, A., Teitelbaum, D., and Fuchs, S., Archs Neurol., (in the press).
Fambrough, D. M., Drachman, D. B., and Satyamurti, S., Science, 182, 293–295 (1973).
Patrick, J., and Lindstrom, J., Science, 180, 871–872 (1973).
Heilbronn, E., Mattson, C., Stalberg, E., and Hilton-Brown, P., J. neurol. Sci., 24, 59–64 (1975).
Aharonov, A., Kalderon, N., Silman, I., and Fuchs, S., Immunochemistry (in the press).
Tarrab, R., Sulica, A., Haimovich, J., and Sela, M., Eur. J. Immun., 1, 231–236 (1971).
Simpson, J. A., Scot. Med. J., 5, 419–436 (1960).
Nastuk, W. L., Plescia, O. J., and Osserman, K. E., Proc. Soc. exp. Biol. Med., 105, 177–184 (1960).
Goldstein, G., Strauss, A. J. L., and Pickeral, S., Clin. exp. Immun., 4, 3–16 (1969).
Kalden, J. R., Williamson, W. G., Johnston, R. J., and Irvine, W. J., Clin. exp. Immun., 5, 319–340 (1969).
Kawanami, S., and Mori, R., Clin. exp. Immun., 12, 447–454 (1972).
Vetters, J. M., Simpson, J. A., and Folkarde, A., Lancet, i, 28–31 (1969).
Kaufman, B. M., Rushworth, G., and Wright, R., J. neurol. neurosurg. Psychiat., 32, 281–289 (1969).
Jones, S. F., Brennan, J. L., and McLeod, J. G., J. neurol. neurosurg. Psychiat., 34, 399–403 (1971).
Hall, Z. W. A., Rev. Biochem., 41, 925–952 (1972).
Sugiyama, H., Benda, P., Meunier, J. C., and Changeux, J. P., FEBS Lett., 35, 124–128 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
TARRAB-HAZDAI, R., AHARONOV, A., SILMAN, I. et al. Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor. Nature 256, 128–130 (1975). https://doi.org/10.1038/256128a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/256128a0
This article is cited by
-
Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status
Drugs (2019)
-
Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys
Scientific Reports (2017)
-
Acetylcholine Receptor-Induced Experimental Myasthenia Gravis: What Have We Learned from Animal Models After Three Decades?
Archivum Immunologiae et Therapiae Experimentalis (2012)
-
Myasthenia gravis as a prototype autoimmune receptor disease
Immunologic Research (1997)
-
Myasthenia gravis: An autoimmune response against the acetylcholine receptor
Immunologic Research (1993)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
